Related Experiment Videos

Intensive cholesterol-lowering therapy improves large artery elasticity in acute myocardial infarction patients

Xinwei Jia1, Meng Wei, Xianghua Fu

  • 1Cardiovascular Department, Second Hospital of Hebei Medical University, Shijiazhuang, P.R. China.

Heart and Vessels
|September 29, 2009
PubMed

Insights

Simvastatin therapy significantly improves large artery elasticity in acute myocardial infarction patients by lowering cholesterol. Patients with hypercholesterolemia experienced greater improvements in arterial elasticity and atherosclerosis regression.

Area of Science:

  • Cardiology
  • Pharmacology
  • Vascular Medicine

Background:

  • Acute myocardial infarction (AMI) patients often exhibit impaired large artery elasticity.
  • Cholesterol management is crucial in cardiovascular disease, particularly post-AMI.
  • The impact of intensive cholesterol-lowering on arterial function in AMI requires further elucidation.

Purpose of the Study:

  • To investigate the effects of intensive simvastatin therapy on large artery elasticity in AMI patients.
  • To compare the therapeutic response between normocholesterolemic and hypercholesterolemic AMI patients.

Main Methods:

  • 72 AMI patients were divided into normocholesterol (n=37) and hypercholesterol (n=35) groups.
  • All patients received oral simvastatin 40 mg/day for 6 months.
  • Pulse-wave velocity (PWV) and ankle-brachial index (ABI) were measured pre- and post-therapy.

Main Results:

  • Simvastatin significantly reduced low-density lipoprotein cholesterol in both groups (P < 0.01).
  • Significant improvements in PWV and ABI were observed in both groups (P < 0.05).
  • The hypercholesterol group showed greater improvements in PWV and ABI compared to the normocholesterol group (P < 0.05).

Conclusions:

  • Intensive simvastatin therapy improves large artery elasticity and regresses atherosclerosis in AMI patients.
  • Hypercholesterolemic AMI patients derive greater benefits from simvastatin therapy regarding arterial elasticity.
  • Simvastatin is an effective treatment for enhancing vascular function in post-AMI individuals.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...